Northern Trust Corp Summit Therapeutics Inc. Transaction History

Northern Trust Corp

$572 Billion
Q1 2024

A detailed history of Northern Trust Corp transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Northern Trust Corp holds 1,072,714 shares of SMMT stock, worth $8.37 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,072,714

Previous 1,108,089 3.19%

Holding current value

$8.37 Million

Previous $2.89 Million 53.56%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$2.55 - $5.07 $90,206 - $179,351	-35,375 Reduced 3.19%	1,072,714 $4.44 Million
Q4 2023 Feb 13, 2024	BUY	$1.67 - $2.83 $66,115 - $112,039	39,590 Added 3.71%	1,108,089 $2.89 Million
Q3 2023 Nov 13, 2023	BUY	$1.54 - $2.42 $59,223 - $93,065	38,457 Added 3.73%	1,068,499 $2 Million
Q2 2023 Aug 11, 2023	BUY	$1.32 - $2.81 $1.27 Million - $2.71 Million	963,409 Added 1445.84%	1,030,042 $2.59 Million
Q1 2023 May 15, 2023	BUY	$1.38 - $5.41 $22,271 - $87,311	16,139 Added 31.96%	66,633 $116,000

Q4 2022 Feb 13, 2023	BUY	$0.68 - $5.31 $18,761 - $146,508	27,591 Added 120.47%	50,494 $214,000
Q3 2022 Nov 14, 2022	BUY	$0.89 - $1.63 $20,383 - $37,331	22,903 New	22,903 $27,000
Q2 2022 Aug 12, 2022	SELL	$0.92 - $2.38 $161,627 - $418,123	-175,682 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$2.0 - $3.45 $34,240 - $59,064	-17,120 Reduced 8.88%	175,682 $431,000
Q4 2021 Feb 08, 2022	SELL	$2.45 - $5.64 $3,096 - $7,128	-1,264 Reduced 0.65%	192,802 $518,000
Q3 2021 Nov 15, 2021	BUY	$4.83 - $8.27 $771,887 - $1.32 Million	159,811 Added 466.53%	194,066 $972,000
Q2 2021 Aug 13, 2021	BUY	$5.15 - $8.46 $176,413 - $289,797	34,255 New	34,255 $256,000

Others Institutions Holding SMMT

# of Institutions

107

Shares Held

41.3M

Call Options Held

103K

Put Options Held

29.9K

View Full List

About Summit Therapeutics Inc.

Ticker SMMT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,215,008
Market Cap $1.57B
Description
Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...

More about SMMT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Summit Therapeutics Inc. Transaction History